切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (01) : 31 -35. doi: 10.3877/cma.j.issn.1674-0785.2019.01.007

所属专题: 文献

临床研究

急性高脂血症性胰腺炎患者血清chemerin与降钙素原变化及意义
汤娜娜1, 王晓燕1, 赵成光1, 蒋波1, 张石玉1, 朱季军1,()   
  1. 1. 223800 江苏宿迁,宿迁市第一人民医院消化科
  • 收稿日期:2018-11-25 出版日期:2019-01-01
  • 通信作者: 朱季军

Serum chemerin and PCT levels in patients with hyperlipidemic acute pancreatitis

Nana Tang1, Xiaoyan Wang1, Chengguang Zhao1, Bo Jiang1, Shiyu Zhang1, Jijun Zhu1,()   

  1. 1. Department of Gastronterology, the First People′s Hospital of Suqian, Suqian 223800, China
  • Received:2018-11-25 Published:2019-01-01
  • Corresponding author: Jijun Zhu
  • About author:
    Corresponding author: Zhu Jijun, Email:
引用本文:

汤娜娜, 王晓燕, 赵成光, 蒋波, 张石玉, 朱季军. 急性高脂血症性胰腺炎患者血清chemerin与降钙素原变化及意义[J]. 中华临床医师杂志(电子版), 2019, 13(01): 31-35.

Nana Tang, Xiaoyan Wang, Chengguang Zhao, Bo Jiang, Shiyu Zhang, Jijun Zhu. Serum chemerin and PCT levels in patients with hyperlipidemic acute pancreatitis[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(01): 31-35.

目的

探讨急性高脂血症性胰腺炎(HLAP)患者中血清chemerin、降钙素原(PCT)水平变化及临床意义。

方法

入选2016年1月至2018年7月在宿迁市第一人民医院住院的82例HLAP患者,按其病情程度分为重症急性胰腺炎(SAP)组(34例)、轻症急性胰腺炎(MAP)组(48例),以50例体检健康者作为健康对照组。应用酶联免疫吸附试验法检测血清chemerin水平,采用荧光酶标免疫测试仪测定血清PCT水平。应用t检验对健康对照者和MAP组、SAP组患者的血清chemerin、PCT水平,HLAP死亡患者和未死亡患者的血清chemerin、PCT水平进行组间比较。应用Pearson法对HLAP患者血清chemerin、PCT水平的相关性,HLAP患者血清chemerin、PCT水平与血生化指标、AP严重程度的相关性进行分析。

结果

健康对照者和MAP组、SAP组患者血清chemerin水平依次增高[(303.7±106.9)μg/L、(472.9 ± 158.6)μg/L、(653.4±229.3)μg/L],两两比较差异均具有统计学意义(P均<0.01)。健康对照组、MAP组、SAP组血清PCT水平依次增高[(1.78±0.95)μg/L、(5.29±2.54)μg/L、(8.21±4.23)μg/L],两两比较差异均具有统计学意义(P均<0.01)。HLAP患者血清chemerin水平和PCT水平呈正相关(r=0.325,P=0.018)。HLAP患者血清chemerin水平与血TG、总胆固醇、CRP水平呈正相关(r=0.521,0.378,0.423,P=0.003,0.005,0.005),与血淀粉酶、乳酸脱氢酶无相关性(r=0.154、0.215,P均>0.05);血清PCT水平与血CRP、乳酸脱氢酶呈正相关(r=0.420,0.430,P=0.004,0.004),与血TG、总胆固醇、淀粉酶无相关性(r=0.182,0.144,0.210,P均>0.05)。HLAP患者血清chemerin水平与24 h急性生理与慢性健康评分(APACHE)Ⅱ、Ranson评分呈正相关(r=0.370、0.428,P=0.024,0.013);血清PCT水平与24 h APACHE Ⅱ、Ranson评分呈正相关(r=0.376、0.320,P=0.018,0.021)。SAP组死亡患者6例,死亡患者血清chemerin、PCT水平与未死亡患者比较[(770.6±182.3)μg/L vs (678.3±246.5)μg/L,(10.60±3.87)μg/L vs (7.45±3.58)μg/L],差异无统计学意义(P均>0.05)。

结论

HLAP患者血清chemerin、PCT水平显著升高,且与病情严重程度呈正相关。血清chemerin和PCT可作为潜在的评估HLAP患者病情严重程度的指标。

Objective

To investigate the serum levels of chemerin and procalcitonin (PCT) in patients with hyperlipidemic acute pancreatitis (HLAP), and to explore their changes and significance.

Methods

A total of 82 HLAP patients admitted to the First People′s Hospital of Suqian from January 2016 to July 2018 were selected. The patients were classified into severe acute pancreatitis (SAP) patients (34 cases) and mild acute pancreatitis (MAP) patients (48 cases). Fifty healthy adults were included as a healthy control group. Serum levels of chemerin were measured using an ELISA kit, and the levels of PCT were measured by immunoassay. The t-test was used to compare serum chemerin and PCT between the healthy control group, MAP group, and SAP group, as well as between the death and non-death groups. Pearson method was used to analyze the correlation between serum chemerin and PCT, as well as between serum chemerin or PCT and blood biochemical indicators or the severity of acute pancreatitis.

Results

Compared with the healthy control group [(303.7±106.9) μg/L], serum chemerin level significantly increased in the MAP group [(472.9 ± 158.6) μg/L] and SAP group [(653.4±229.3) μg/L], and pairwise comparisons were statistically significant (P<0.01). Compared with the healthy control group [(1.78±0.95) μg/L], serum PCT also increased significantly in the MAP group [(5.29±2.54) μg/L] and SAP group [(8.21±4.23) μg/L], and pairwise comparisons were statistically significant (P<0.01). Serum levels of chemerin were positively correlated with those of PCT (r=0.325, P=0.018). Serum level of chemerin were positively correlated with serum levels of TG, total cholesterol, and CRP (r=0.521, 0.378, 0.423, P=0.003, 0.005, 0.005), but had no correlation with serum amylase or lactate dehydrogenase (r=0.154、0.215, P>0.05); Serum levels of PCT were positively correlated with serum levels of CRP and lactate dehydrogenase (r=0.420, 0.430, P=0.004, 0.004), but had no correlation with serum TG, total cholesterol, and amylase (r=0.182, 0.144, 0.210, P>0.05). Serum levels of chemerin and PCT were both positively correlated with APACHE II and Ranson score (r=0.370, 0.428, P=0.024, 0.013; r=0.376, 0.320, P=0.018, 0.021). Six patients died of SAP. There was no significant difference in chemerin or PCT level between the dead patients and non-dead patients [(770.6±182.3) μg/L vs (678.3±246.5) μg/L, (10.60±3.87) μg/L vs (7.45±3.58) μg/L, P>0.05].

Conclusion

In HLAP patients, serum chemerin and PCT levels significantly increase and positively correlate with disease severity. These results suggest that chemerin and PCT may act as potential serum markers for HLAP severity evaluation.

表1 健康对照者和MAP组、SAP组患者血清chemerin、PCT水平比较(±s
表2 HLAP患者血清chemerin水平与血生化指标、AP严重程度相关性
表3 HLAP患者血清PCT水平与血生化指标、AP严重程度相关性
1
孙诚谊,潘耀振. 高脂血症性急性胰腺炎的发病机制及诊疗进展[J]. 世界华人消化杂志, 2008, 16(4): 343-349.
2
Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity [J]. Trends Endocrinol Metab, 2010, 21(11): 660-667.
3
Fülöp P, Seres I, Lőrincz H, et al. Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients [J]. J Cell Mol Med, 2014, 18(7): 1313-1320.
4
陈军,汤净,曾世平. 急性胰腺炎患者血清chemerin水平及对预后的影响[J]. 中国老年学杂志, 2012, 32(16): 3530-3531.
5
辛宪磊,冯健,陈永亮, 等. 重症急性胰腺炎大鼠血清Chemerin水平变化的实验研究[J]. 解放军医学院学报, 2013, 34(6): 632-634, 643.
6
Deng LH, Xue P, Xia Q, et al. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis [J]. World J Gastroenterol, 2008, 14(28): 4558-4561.
7
Bozaoglu K, Bolton K, McMillan J,et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J]. Endocrinology, 2007, 148(10): 4687-4694.
8
Roh SG, Song SH, Choi KC,et al.Chemerin-a new adipokine that modulates adipogenesis via its own receptor [J]. Biochem Biophys Res Commun, 2007, 362(4): 1013-1018.
9
Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes [J]. Clin Endocrinol (Oxf), 2010, 72(3): 342-348.
10
Koksal AR, Boga S, Alkim H, et al. Chemerin: a new biomarker to predict postendoscopic retrograde cholangiopancreatography pancreatitis [J]. Eur J Gastroenterol Hepatol, 2016, 28(6): 714-721.
11
李红昌,雷若庆,许志伟, 等. 急性胰腺炎大鼠血和组织中降钙素原水平的变化[J].中华胰腺病杂志, 2010, 10(3): 187-189.
12
Qu R, Ji Y, Ling Y, et al. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial [J]. Saudi Med J, 2012, 33(4): 382-387.
[1] 张秋彬, 张楠, 林清婷, 徐军, 朱华栋, 姜辉. 急性胰腺炎合并急性肾损伤患者的预后评估[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 382-389.
[2] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[3] 廖锵云, 王震, 林洁玉, 廖夏, 邓锦华, 李杰峰, 邓建维, 李明, 荣新洲. 虎门地区创伤弧菌感染的临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 394-398.
[4] 黄翠君, 张喜玲, 刘思嘉, 刘云建. 重症急性胰腺炎营养支持治疗研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(05): 385-390.
[5] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[6] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[7] 伍学成, 李远伟, 袁武雄, 王建松, 石泳中, 卢强, 李卓, 陈佳, 刘哲, 滕伊漓, 高智勇. 炎症介质谱联合降钙素原在尿源性脓毒血症中的诊断价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 476-480.
[8] 陈海艳, 周惠敏, 崔佳琪, 杨军. 经尿道膀胱镜钬激光碎石术后并发中度重症急性胰腺炎一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 461-463.
[9] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[10] 陆萍, 邹健. 凝血和纤维蛋白溶解标志物的动态变化对急性胰腺炎患者预后的评估价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 427-432.
[11] 吉茜茜, 田尧, 马林, 钱进. 红细胞分布宽度-白蛋白比值联合BISAP评分对急性胰腺炎严重程度及死亡率的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 433-438.
[12] 黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[13] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[14] 孙旻. 血液淀粉酶、C反应蛋白、降钙素原及乳酸脱氢酶在急性胰腺炎患者病情评价及预后预测中的价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 331-336.
[15] 马强, 李军, 苟丽娟. 重症急性胰腺炎miR-21-3p、RUNX3表达水平及对病情发展程度的预测[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 337-341.
阅读次数
全文


摘要